Annual Total Liabilities
$6.25 M
+$127.00 K+2.07%
December 31, 2023
Summary
- As of February 10, 2025, LABP annual total liabilities is $6.25 million, with the most recent change of +$127.00 thousand (+2.07%) on December 31, 2023.
- During the last 3 years, LABP annual total liabilities has fallen by -$78.10 million (-92.59%).
Performance
LABP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$6.74 M
+$493.00 K+7.89%
March 31, 2024
Summary
- As of February 10, 2025, LABP quarterly total liabilities is $6.74 million, with the most recent change of +$493.00 thousand (+7.89%) on March 31, 2024.
- Over the past year, LABP quarterly total liabilities has increased by +$1.18 million (+21.13%).
Performance
LABP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LABP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.1% | +21.1% |
| 3 y3 years | -92.6% | -25.4% |
| 5 y5 years | +247.9% | -91.1% |
LABP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.4% | -2.0% | -59.4% | -55.3% |
| 5 y | 5-year | -92.6% | -2.0% | -92.0% | -55.3% |
| alltime | all time | -92.6% | -71.3% | -92.0% | -55.3% |
Landos Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $6.74 M(+7.9%) |
| Dec 2023 | $6.25 M(+2.1%) | $6.25 M(+12.3%) |
| Sep 2023 | - | $5.57 M(+84.6%) |
| Jun 2023 | - | $3.02 M(-27.5%) |
| Mar 2023 | - | $4.16 M(-32.0%) |
| Dec 2022 | $6.12 M | $6.12 M(+11.8%) |
| Sep 2022 | - | $5.47 M(-15.9%) |
| Jun 2022 | - | $6.51 M(-58.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.51 M(-6.6%) |
| Dec 2021 | $16.61 M(-80.3%) | $16.61 M(+48.6%) |
| Sep 2021 | - | $11.18 M(-11.8%) |
| Jun 2021 | - | $12.68 M(+40.4%) |
| Mar 2021 | - | $9.03 M(-89.3%) |
| Dec 2020 | $84.35 M(+10.9%) | $84.35 M(+4.1%) |
| Sep 2020 | - | $81.00 M(+6.5%) |
| Dec 2019 | $76.06 M(+4135.1%) | $76.06 M |
| Dec 2018 | $1.80 M | - |
FAQ
- What is Landos Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Landos Biopharma?
- What is Landos Biopharma annual total liabilities year-on-year change?
- What is Landos Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Landos Biopharma?
- What is Landos Biopharma quarterly total liabilities year-on-year change?
What is Landos Biopharma annual total liabilities?
The current annual total liabilities of LABP is $6.25 M
What is the all time high annual total liabilities for Landos Biopharma?
Landos Biopharma all-time high annual total liabilities is $84.35 M
What is Landos Biopharma annual total liabilities year-on-year change?
Over the past year, LABP annual total liabilities has changed by +$127.00 K (+2.07%)
What is Landos Biopharma quarterly total liabilities?
The current quarterly total liabilities of LABP is $6.74 M
What is the all time high quarterly total liabilities for Landos Biopharma?
Landos Biopharma all-time high quarterly total liabilities is $84.35 M
What is Landos Biopharma quarterly total liabilities year-on-year change?
Over the past year, LABP quarterly total liabilities has changed by +$1.18 M (+21.13%)